by Life Sciences Nova Scotia | Jul 18, 2024 | News
Date: July 18, 2024 Effective July 15, 2024, Nova Scotia Health and Life Sciences Nova Scotia have announced an agreement to enhance collaboration between the two organizations. Doris Grant, CEO of Life Sciences Nova Scotia, will assume the role of Managing Director...
by Life Sciences Nova Scotia | May 21, 2024 | News
Date: May 21, 2024 Halifax, Nova Scotia, May 21, 2024 – Life Sciences Nova Scotia (LSNS) has announced that Sean Awalt will be stepping down from his role as Chief Executive Officer (CEO) on May 21, 2024, to pursue a new opportunity in industry. The LSNS Board of...
by Life Sciences Nova Scotia | May 15, 2024 | News
From: NovaResp / EINPresswire.com Date: May 14, 2024 NovaResp Technologies Inc. proudly announced it has successfully raised a $3.0 million seed extension round led by Dr. Neil Smith, an otolaryngologist and company board member. The convertible debenture round was...
by Life Sciences Nova Scotia | Apr 18, 2024 | News
BioPort Atlantic 2024 Conference: Celebrating Atlantic Canada’s Life Sciences Innovations Date: April 18, 2024 BioPort Atlantic, Atlantic Canada’s premier life sciences summit, is excited to announce its 23rd annual conference, taking place September 17-19th at...
by Life Sciences Nova Scotia | Apr 17, 2024 | News
Nova Scotia is partnering with Novo Nordisk Canada Inc. to create the Nova Scotia Lighthouse project, an initiative that will address childhood obesity and chronic disease in the province. From: Health and Wellness, Premier’s Office – Nova Scotia Date:...
by Life Sciences Nova Scotia | Feb 26, 2024 | News
From: BIOVECTRA Date: Feb. 26, 2024 BIOVECTRA Partners on Canadian Solution to Establish a Domestic Supply Chain For Immunotherapies BIOVECTRA is pleased to be part of a Canadian solution with our NGEN partners CCRM, Precision Nanosytems (Cytiva), Northern RNA,...